AI cancer screening programs are booming, but you'll likely have to pay for them yourself
Publishing timestamp: 2024-05-30 10:08:31
Summary
The FDA has approved nearly 600 radiology artificial intelligence and machine learning programs over the last five years, but most are not covered by insurance. Medical associations and regulators are cautious about designating new programs for reimbursement. Startups like Avenda Health are facing challenges in getting insurance reimbursement for their AI-enhanced cancer screening programs, hindering adoption. RadNet charges patients cash fees for its AI-enhanced breast cancer screening. The lack of reimbursement is a barrier to the adoption of new AI programs for cancer screening, but investors remain optimistic about the sector.
Sentiment: MIXED
Tickers: RDNT,
Keywords: breaking news: technology, radnet inc, technology, health care industry, business news,
Source: https://www.cnbc.com/2024/05/30/ai-cancer-screening-is-booming-most-not-covered-by-insurance-.html